BVS — Bioventus Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Bioventus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	42.8	64.5	86.8	43.9	31.8
Net Total Accounts Receivable
Net Total Receivables	73	85.4	88.4	125	137
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	148	183	212	263	273
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.76	19.8	21.8	40.2	45
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	443	472	494	1,226	1,373
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	65.4	89	123	181	304
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	297	329	352	767	1,056
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	145	143	142	459	317
Total Liabilities & Shareholders' Equity	443	472	494	1,226	1,373
Total Common Shares Outstanding